Tokyo and Basking Ridge, NJ – (October 30, 2024) – The first patients have been dosed in three global, randomized phase 3 trials...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) October 28, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada,...

THURSDAY, Oct. 31, 2024 -- Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus...

A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...

Cancer patients who quit smoking within six months of diagnosis significantly improve their survival chances, according to a new study from The...

A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

TUESDAY, Oct. 29, 2024 -- Restaging magnetic resonance imaging (MRI) can predict organ preservation and survival with rectal cancer, according to a...

The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to...

Medicaid expansion linked to better cancer care and survival rates for patients with aggressive breast cancer.